Overview
Status
Suspended
Registry date
2020-04-28
Share capital
5,000.00 PLN
Financials
Revenue history
Filing timeliness
No financial statement for 2022 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2021, 59 days late).
- 2022not filed
- 202112/09/2022
- 202005/08/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2021.
Results vs industry
Revenue
This companyUSD 580.36MedianUSD 287.80kAverageUSD 4.90m
Net profit
This companyUSD -65.40MedianUSD 12.59kAverageUSD 208.64k
Operating costs
This companyUSD 645.70MedianUSD 272.78kAverageUSD 4.48m
Assets
This companyUSD 26.90kMedianUSD 224.38kAverageUSD 5.76m
Industry
Authorized Representatives
Adam Kądziela – Management Board Member
Stanisław Jan Binkiewicz – Management Board Member
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Stanisław Jan Binkiewiczage 45 | 55 | $742.84 | 55% |
Adam Kądzielaage 43 | 45 | $607.78 | 45% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2021-05-01 to 2025-09-30.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 10, 2020 | Aid for SME access to finance — aid for start-ups | $50,781$50,781 | Łódzka Specjalna Strefa Ekonomiczna S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| JZOS.A. | $41,048,656.33 | jzo.com.pl | ||
| InmedS.A. | $13,860,648.96 | inmed.pl | ||
| Platinumsp. z o.o. | $313,097.87 | platinum-klinika.pl | ||
| Markdentsp. z o.o. | $129,752.97 | mark-dent.pl | ||
| K&J Polskasp. z o.o. | $70,953.51 | kjpolska.pl | ||
| Hemolens Diagnosticssp. z o.o. | $37,964.68 | hemolens.com | ||
| Pragma System Globalsp. z o.o. | $34,880.66 | pragma.systems | ||
| Selex Polskasp. z o.o. | $7,765.44 | selexpolska.com | ||
| Hetaloxsp. z o.o. | $965.71 | hetalox.com | ||
| Spinetime Solutionssp. z o.o. | – | spinetime.eu |
Change history
| Date | Event | |
|---|---|---|
| 2025-10-03 | Business suspended | |
| 2025-05-28 | Business resumed | |
| 2021-10-20 | Business suspended | |
| 2021-06-18 | Address change (Ul. Duńska 13, 54-427, Wrocław → Ul. Władysława Grabskiego 22, 55-011, Siechnice) | |
| 2020-04-28 | Entered in the register |
FAQ
The main business activity of Viotara focuses on manufacture of medical and dental instruments and supplies.
The company was registered in the Polish National Court Register (KRS) on April 28, 2020.
The headquarters is located at: ul. Władysława Grabskiego 22, 55-011 Siechnice.
The management board consists of: Adam Kądziela (Member of the Management Board) and Stanisław Jan Binkiewicz (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2021 to December 31, 2021.
Last updated: 2026-04-19